Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Тенденции развития инсулинорезистентности: механизмы и терапевтические стратегии
2022-07-06
SCID: 54.1/egufv4rr
Discuss with AI
adipokinesinsulin resistanceinsulin sensitivitymetabolic dysfunction-associated fatty liver diseasemetabolic syndrome
Figures from the paper
Abstract (AI)
The centenary of insulin discovery represents an important opportunity to transform diabetes from a fatal diagnosis into a medically manageable chronic condition. Insulin is a key peptide hormone and mediates the systemic glucose metabolism in different tissues. Insulin resistance (IR) is a disordered biological response for insulin stimulation through the disruption of different molecular pathways in target tissues. Acquired conditions and genetic factors have been implicated in IR. Recent genetic and biochemical studies suggest that the dysregulated metabolic mediators released by adipose tissue including adipokines, cytokines, chemokines, excess lipids and toxic lipid metabolites promote IR in other tissues. IR is associated with several groups of abnormal syndromes that include obesity, diabetes, metabolic dysfunction-associated fatty liver disease (MAFLD), cardiovascular disease, polycystic ovary syndrome (PCOS), and other abnormalities. Although no medication is specifically approved to treat IR, we summarized the lifestyle changes and pharmacological medications that have been used as efficient intervention to improve insulin sensitivity. Ultimately, the systematic discussion of complex mechanism will help to identify potential new targets and treat the closely associated metabolic syndrome of IR.
Key Findings
1
Although no medication is specifically approved for insulin resistance, lifestyle modification and pharmacological treatments can improve insulin sensitivity; mechanistic understanding may reveal new therapeutic targets.
2
Both acquired conditions and genetic factors contribute to the development of insulin resistance.
3
Dysregulated adipose-derived mediators—including adipokines, cytokines, chemokines, excess lipids, and toxic lipid metabolites—can promote insulin resistance in other tissues.
4
Insulin resistance is associated with obesity, diabetes, metabolic dysfunction-associated fatty liver disease, cardiovascular disease, and polycystic ovary syndrome.
5
Insulin resistance reflects impaired biological responses to insulin caused by disruption of molecular signaling pathways in target tissues.
Research Object
insulin resistance in systemic glucose-metabolism tissues and associated metabolic syndromes
Research Subject
molecular and metabolic mechanisms underlying insulin resistance and lifestyle and pharmacological strategies to improve insulin sensitivity
Publication Details
Publication Date
2022-07-06
Journal
Publisher
ISSN
Cited by
1087
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Structure, function and diversity of the healthy human microbiome2012
Double-slit photoelectron interference in strong-field ionization of the neon dimer2018
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases2019
Association between insulin resistance and the development of cardiovascular disease2018
The Discovery and Development of Liraglutide and Semaglutide2019
The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion2002